8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Join Veristat at the 2017 ASCO Annual Meeting, the world’s largest annual gathering of oncology healthcare and clinical research professionals taking place from June 2-6, 2017 in Chicago, IL. It is anticipated that more than 38,000 attendees will convene this year to achieve the conference theme of “Making a Difference in Cancer Care WITH YOU”
Veristat will be sending a team of our oncology clinical trial experts to ASCO this year, including:
Jim Roach
Chief Medical Officer
Theresa Bruce
Vice President
Clinical Operations
Cindy Henderson
Executive Vice President of
Strategic Development
Meet up with Veristat while you are at ASCO. Veristat’s experienced teams have helped clients run over 335 Oncology studies for solid tumors, hematologic malignancies and more. Additionally, we’ve worked on over 20 US and European regulatory submission projects for cancer treatments, including many rare cancers.
Schedule a time to speak with Veristat at ASCO on how we can put our oncology clinical trial and regulatory submission experience to work for you. Fill out the form on the right.
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...